Composition
- Active ingredients
- HYDROCORTISONE ACETATE 0.5%; NEOMYCIN SULFATE EQ 3.5MG BASE/GM
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- HYDROCORTISONE ACETATE 2.5%; NEOMYCIN SULFATE EQ 3.5MG BASE/GM · OintmentANDA060751-003 · Discontinued
- HYDROCORTISONE ACETATE 0.5%; NEOMYCIN SULFATE EQ 3.5MG BASE/GM · OintmentThis page
- HYDROCORTISONE ACETATE 1%; NEOMYCIN SULFATE EQ 3.5MG BASE/GM · OintmentANDA060751-002 · Discontinued
- HYDROCORTISONE ACETATE 1.5%; NEOMYCIN SULFATE EQ 3.5MG BASE/GM · OintmentANDA060610-002 · Discontinued
- HYDROCORTISONE ACETATE 0.5%; NEOMYCIN SULFATE EQ 3.5MG BASE/GM · OintmentANDA060610-001 · Discontinued
- HYDROCORTISONE ACETATE 1.5%; NEOMYCIN SULFATE EQ 3.5MG BASE/ML · Suspension/dropsANDA060612-001 · Discontinued
- HYDROCORTISONE ACETATE 0.5%; NEOMYCIN SULFATE EQ 3.5MG BASE/ML · Suspension/dropsANDA060612-002 · Discontinued
- HYDROCORTISONE ACETATE 2.5%; NEOMYCIN SULFATE EQ 3.5MG BASE/GM · CreamANDA061049-002 · Discontinued
- HYDROCORTISONE ACETATE 1%; NEOMYCIN SULFATE EQ 3.5MG BASE/GM · CreamANDA061049-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA060751.
At a glance
- Brand name
- Neo-Cortef
- Active substance
- hydrocortisone acetate
- Route
- Topical
- Dosage form
- Ointment
- Applicant
- Pharmacia and Upjohn
- Status
- Discontinued
- FDA approval
- 18 May 1965
- Application
- ANDA060751-001